Research ArticleOncology
Validation of Metabolically Active Tumor Volume and Total Lesion Glycolysis as 18F-FDG PET/CT–derived Prognostic Biomarkers in Chemorefractory Metastatic Colorectal Cancer
Erwin Woff, Alain Hendlisz, Lieveke Ameye, Camilo Garcia, Tarek Kamoun, Thomas Guiot, Marianne Paesmans and Patrick Flamen
Journal of Nuclear Medicine February 2019, 60 (2) 178-184; DOI: https://doi.org/10.2967/jnumed.118.210161
Erwin Woff
1Nuclear Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium
Alain Hendlisz
2Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels (ULB), Belgium; and
Lieveke Ameye
3Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium
Camilo Garcia
1Nuclear Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium
Tarek Kamoun
1Nuclear Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium
Thomas Guiot
1Nuclear Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium
Marianne Paesmans
3Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium
Patrick Flamen
1Nuclear Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 60, Issue 2
February 1, 2019
Validation of Metabolically Active Tumor Volume and Total Lesion Glycolysis as 18F-FDG PET/CT–derived Prognostic Biomarkers in Chemorefractory Metastatic Colorectal Cancer
Erwin Woff, Alain Hendlisz, Lieveke Ameye, Camilo Garcia, Tarek Kamoun, Thomas Guiot, Marianne Paesmans, Patrick Flamen
Journal of Nuclear Medicine Feb 2019, 60 (2) 178-184; DOI: 10.2967/jnumed.118.210161
Validation of Metabolically Active Tumor Volume and Total Lesion Glycolysis as 18F-FDG PET/CT–derived Prognostic Biomarkers in Chemorefractory Metastatic Colorectal Cancer
Erwin Woff, Alain Hendlisz, Lieveke Ameye, Camilo Garcia, Tarek Kamoun, Thomas Guiot, Marianne Paesmans, Patrick Flamen
Journal of Nuclear Medicine Feb 2019, 60 (2) 178-184; DOI: 10.2967/jnumed.118.210161
Jump to section
Related Articles
Cited By...
- Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer
- Dose-Response and Dose-Toxicity Relationships for Glass 90Y Radioembolization in Patients with Liver Metastases from Colorectal Cancer
- Radiomics Features of 18F-fluorodeoxyglucose Positron-Emission Tomography as a Novel Prognostic Signature in Colorectal Cancer